Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Lincan Li, Tianyu Gan, Ziyue Ma, Yi Huang & Jin Zhong. (2023) Assessing risk of Bombali virus spillover to humans by mutagenesis analysis of viral glycoprotein. hLife.
Crossref
Crossref
Rui Yu, Min Wang, Lizhen Liu, Jingjing Yan, Jun Fan, Xiaohong Li, Miaomiao Kang, Jianqing Xu, Xiaoyan Zhang & Shuye Zhang. (2023) The development and characterization of a stable Coxsackievirus A16 infectious clone with Nanoluc reporter gene. Frontiers in Microbiology 13.
Crossref
Crossref
Tianyu Gan, Dihan Zhou, Yi Huang, Shuqi Xiao, Ziyue Ma, Xiaoyou Hu, Yimin Tong, Huimin Yan & Jin Zhong. (2021) Development of a New Reverse Genetics System for Ebola Virus. mSphere 6:3.
Crossref
Crossref
Ameer Khusro & Chirom Aarti. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines
143
162
.
João Pedro Fonseca, Alain R. Bonny, G. Renuka Kumar, Andrew H. Ng, Jason Town, Qiu Chang Wu, Elham Aslankoohi, Susan Y. Chen, Galen Dods, Patrick Harrigan, Lindsey C. Osimiri, Amy L. Kistler & Hana El-Samad. (2019) A Toolkit for Rapid Modular Construction of Biological Circuits in Mammalian Cells. ACS Synthetic Biology 8:11, pages 2593-2606.
Crossref
Crossref
Thomas Hoenen, Allison Groseth & Heinz Feldmann. (2019) Therapeutic strategies to target the Ebola virus life cycle. Nature Reviews Microbiology 17:10, pages 593-606.
Crossref
Crossref
Thomas Lane, Manu Anantpadma, Joel S. Freundlich, Robert A. Davey, Peter B. Madrid & Sean Ekins. (2019) The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro. Pharmaceutical Research 36:7.
Crossref
Crossref
Ting Shu, Tianyu Gan, Peng Bai, Xiaotong Wang, Qi Qian, Hui Zhou, Qi Cheng, Yang Qiu, Lei Yin, Jin Zhong & Xi Zhou. (2019) Ebola virus VP35 has novel NTPase and helicase-like activities. Nucleic Acids Research 47:11, pages 5837-5851.
Crossref
Crossref
Cristiano Salata, Arianna Calistri, Gualtiero Alvisi, Michele Celestino, Cristina Parolin & Giorgio Palù. (2019) Ebola Virus Entry: From Molecular Characterization to Drug Discovery. Viruses 11:3, pages 274.
Crossref
Crossref
Scott Martin, Abhilash I. Chiramel, Marie Luisa Schmidt, Yu-Chi Chen, Nadia Whitt, Ari Watt, Eric C. Dunham, Kyle Shifflett, Shelby Traeger, Anne Leske, Eugen Buehler, Cynthia Martellaro, Janine Brandt, Lisa Wendt, Andreas Müller, Stephanie Peitsch, Sonja M. Best, Jürgen Stech, Stefan Finke, Angela Römer-Oberdörfer, Allison Groseth, Heinz Feldmann & Thomas Hoenen. (2018) A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle. Genome Medicine 10:1.
Crossref
Crossref
Marie Luisa Schmidt, Birke Andrea Tews, Allison Groseth & Thomas Hoenen. (2018) Generation and Optimization of a Green Fluorescent Protein-Expressing Transcription and Replication-Competent Virus-Like Particle System for Ebola Virus. The Journal of Infectious Diseases 218:suppl_5, pages S360-S364.
Crossref
Crossref
Nakyung Lee, David Shum, Alexander König, Hichul Kim, Jinyeong Heo, Saehong Min, Jihye Lee, Yoonae Ko, Inhee Choi, Honggun Lee, Constantin Radu, Thomas Hoenen, Ji-Young Min & Marc P. Windisch. (2018) High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system. Antiviral Research 158, pages 226-237.
Crossref
Crossref
Eric C. Dunham, Anne Leske, Kyle Shifflett, Ari Watt, Heinz Feldmann, Thomas Hoenen & Allison Groseth. (2018) Lifecycle modelling systems support inosine monophosphate dehydrogenase (IMPDH) as a pro-viral factor and antiviral target for New World arenaviruses. Antiviral Research 157, pages 140-150.
Crossref
Crossref
Robert W. Cross, Chad E. Mire, Heinz Feldmann & Thomas W. Geisbert. (2018) Post-exposure treatments for Ebola and Marburg virus infections. Nature Reviews Drug Discovery 17:6, pages 413-434.
Crossref
Crossref
Sheli R. Radoshitzky, Veronica Soloveva, Dima Gharaibeh, Jens H. Kuhn & Sina Bavari. 2018. Hemorrhagic Fever Viruses. Hemorrhagic Fever Viruses
393
403
.
Thomas Hoenen. 2018. Hemorrhagic Fever Viruses. Hemorrhagic Fever Viruses
237
245
.
Wanyin Tao, Tianyu Gan, Mingzhe Guo, Yongfen Xu & Jin Zhong. (2017) Novel Stable Ebola Virus Minigenome Replicon Reveals Remarkable Stability of the Viral Genome. Journal of Virology 91:22.
Crossref
Crossref
Marie Luisa Schmidt & Thomas Hoenen. (2017) Characterization of the catalytic center of the Ebola virus L polymerase. PLOS Neglected Tropical Diseases 11:10, pages e0005996.
Crossref
Crossref
Joseph B. Prescott, Andrea Marzi, David Safronetz, Shelly J. Robertson, Heinz Feldmann & Sonja M. Best. (2017) Immunobiology of Ebola and Lassa virus infections. Nature Reviews Immunology 17:3, pages 195-207.
Crossref
Crossref
Laura Baseler, Daniel S. Chertow, Karl M. Johnson, Heinz Feldmann & David M. Morens. (2017) The Pathogenesis of Ebola Virus Disease. Annual Review of Pathology: Mechanisms of Disease 12:1, pages 387-418.
Crossref
Crossref
Nadine Biedenkopf & Thomas Hoenen. 2017. Ebolaviruses. Ebolaviruses
119
131
.
Thomas Hoenen & Heinz Feldmann. 2017. Reverse Genetics of RNA Viruses. Reverse Genetics of RNA Viruses
159
170
.
Md. Koushikul Islam, Maria Baudin, Jonas Eriksson, Christopher Öberg, Matthias Habjan, Friedemann Weber, Anna K. Överby, Clas Ahlm & Magnus Evander. (2016) High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection. SLAS Discovery 21:4, pages 354-362.
Crossref
Crossref
Stephen D. S. McCarthy, Beata Majchrzak-Kita, Trina Racine, Hannah N. Kozlowski, Darren P. Baker, Thomas Hoenen, Gary P. Kobinger, Eleanor N. Fish & Donald R. Branch. (2016) A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus. PLOS Neglected Tropical Diseases 10:1, pages e0004364.
Crossref
Crossref
Chunhui Miao, Minghua Li, Yi-Min Zheng, Fredric S. Cohen & Shan-Lu Liu. (2016) Cell–cell contact promotes Ebola virus GP-mediated infection. Virology 488, pages 202-215.
Crossref
Crossref
Yizhuo Wang, Rui Cui, Guiming Li, Qianqian Gao, Shilin Yuan, Ralf Altmeyer & Gang Zou. (2016) Teicoplanin inhibits Ebola pseudovirus infection in cell culture. Antiviral Research 125, pages 1-7.
Crossref
Crossref
César G. Albariño, Lisa Wiggleton Guerrero, Michael K. Lo, Stuart T. Nichol & Jonathan S. Towner. (2015) Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein. Virology 484, pages 259-264.
Crossref
Crossref
Haoyang Li, Tianlei Ying, Fei Yu, Lu Lu & Shibo Jiang. (2015) Development of therapeutics for treatment of Ebola virus infection. Microbes and Infection 17:2, pages 109-117.
Crossref
Crossref
Paul E. Kilgore, John D. Grabenstein, Abdulbaset M. Salim & Michael Rybak. (2015) Treatment of Ebola Virus Disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:1, pages 43-53.
Crossref
Crossref
Thomas Hoenen & Heinz Feldmann. (2014) Ebolavirus in West Africa, and the use of experimental therapies or vaccines. BMC Biology 12:1.
Crossref
Crossref